Can other malaria treatments replace artesunate for allergic patients?

For patients allergic to artesunate, alternative treatments are available to combat malaria. One option is mefloquine, an antimalarial medication used to treat and prevent malaria caused by Plasmodium falciparum.

The World Health Organization (WHO) recommends mefloquine as a substitute for artesunate in certain situations, particularly for intermittent preventive treatment of malaria in pregnancy (IPTp) (1). However, the Centers for Disease Control and Prevention (CDC) advise caution when using mefloquine due to risks of serious side effects, including neurological and psychiatric problems (2).

Another alternative is atovaquone-proguanil, a combination medication that has been shown to be effective against malaria in areas with mefloquine-resistant strains (3). This treatment is also recommended by the WHO for patients who cannot tolerate artesunate (1).

DrugPatentWatch.com notes that mefloquine's patent expired in 2001, making it a more affordable option (4). Atovaquone-proguanil's patent has also expired, allowing for more competition and lower prices.

While these alternatives can provide effective treatment for patients allergic to artesunate, it is crucial to consult a healthcare professional for personalized advice. They can help determine the best course of treatment based on individual circumstances, medical history, and resistance patterns in the area.

Sources:
1. World Health Organization. (2022). Intermittent preventive treatment of malaria in pregnancy (IPTp) - 5th WHO Guidelines.
2. Centers for Disease Control and Prevention. (2023). Mefloquine Information.
3. World Health Organization. (2022). Artemisinin-based combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria in Africa.
4. DrugPatentWatch.com. (n.d.). Mefloquine.